ACS Current Trends in General Surgery
The American College of Surgeons Division of Education is pleased to present this online course, ACS Current Trends in General Surgery. This virtual course is designed to provide new knowledge or reinforce existing concepts for use in surgical practice, and to assist in preparation for examinations. It is a pragmatic review covering essential content areas in general surgery.
Course Content
- Module 1: GI Oncology
- Module 2: Alimentary
- Module 3: Breast, Skin, Soft Tissue, and Endocrine
- Module 4: Trauma, Critical Care, and Vascular
- Module 5: Perioperative Care
Target Audience
General Surgeons and other surgeons interested in the current practice of general surgery.
Learning Objectives
This educational activity is intended for general surgeons and others seeking a review of general surgery. The course is designed to provide new knowledge or reinforce existing concepts for use in surgical practice, and to assist in preparation for examinations. Learning objectives include:
- Extract new information on key topics in General Surgery such as the Alimentary Tract, Endocrine and Soft Tissue, Oncology, Perioperative Care, Skin and Breast, Surgical Critical Care, Trauma, Specialty Care, and Vascular Surgery.
- Articulate and use newly acquired knowledge directly in clinical settings to enhance patient care outcomes.
- Recognize specific areas for enhancing medical expertise and patient care practices, while also evolving personal improvement strategies.
Contact
- For additional information, contact Michelle McNeilly, MHA, Senior Manager, at mmcneilly@facs.org, or Natalie Loper, MPPA, Administrator, at nloper@facs.org.
- For any technical questions, contact learning@facs.org.
Disclosure Information
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.
Ineligible company
The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.
Financial Relationships
Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.
Conflict of Interest
Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.
Planning Committee Disclosures
Alexandra Istl, MD, FACS - Module Chair and Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
Andrew Kastenmeier, MD, FACS - Planner and Course Co-chair, for this educational event, has financial relationship(s) with: Gore as an educator and received an honorarium.
David E. Meyer, MD, FACS - Module Chair and Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
Laura J. Moore, MD, FACS - Planner and Course Chair, for this educational event, has financial relationship(s) with: 1) Frontline Medical Technologies as a Chair for the Clinical Adv. Board and received stock. 2) Decisio Health Inc is a Clinical Co-founder and received stock.
Tamara E. Saunders, MD, FACS - Module Chair and Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
Speakers / Faculty Disclosures
Mohammad Al Efishat, MD, FSSO - Faculty, for this educational event, has financial relationship(s) with: Intuitive Surgical as a speaker and received compensation.
Megan L. Brenner, MD, FACS - Faculty, for this educational event, has financial relationship(s) with: 1) Up to Date as a speaker and received royalties.
Callisia N. Clarke, MD, FACS - Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
Kyle G. Cologne, MD, FACS - Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose
Bryan A. Cotton, MD, FACS - Faculty, for this educational event, has financial relationship(s) with: 1) Haemonetics as a Scientific Adv. Board, Consultant and received honorarium. 2) Teleflex as a Scientific Adv. Board, Consultant and received honorarium. 3) Cerus as a Scientific Adv. Board, Consultant and received honorarium. 4) Grifols as a Scientific Adv. Board, Consultant and received honorarium.
Jennifer S. Davids, MD, FACS - Faculty, for this educational event, has financial relationship(s) with: 1) Olympus as a speaker and received honorarium. 2) Tavanta as a consultant and received honorarium. 3) SafeHeal as a consultant and received honorarium.
Sophie Dream, MD, FACS - Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
Casey B. Duncan, MD, FACS - Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
Bridget N. Fahy, MD, FACS - Faculty, for this educational event, has financial relationship(s) with: 1) Align Technology Inc is a consultant and received stockholder shares. 2) Biogen Inc is a consultant and received stockholder shares. 3) BRISTOL-MYERS Squibb is a consultant and received stockholder shares. 4) DexCom Inc is a consultant and received stockholder shares. 5) Editas Medicine Inc Com is a consultant and received stockholder shares. 6) Fulgent Genetics Inc is a consultant and received stockholder shares. 7) GoodRX is a consultant and received stockholder shares. 8) Guardant Health is a consultant and received stockholder shares. 9) Globus Medical Inc Class A is a consultant and received stockholder shares. 10) HCA Healthcare Inc is a consultant and received stockholder shares. 11) IDEXX Labs is a consultant and received stockholder shares. 12) Intuitive Surgical is a consultant and received stockholder shares. 13) MASIMO CORP is a consultant and received stockholder shares. 14) Moderna Inc is a consultant and received stockholder shares. 15) Neurocrine Biosciences Inc is a consultant and received stockholder shares. 16) Repligen Corp is a consultant and received stockholder shares. 17) ResMed Inc is a consultant and received stockholder shares. 18) Seagen Inc is a consultant and received stockholder shares. 19) STAAR Surgical Co is a consultant and received stockholder shares. 20) Shockwave Medical Inc is a consultant and received stockholder shares. 21) TELADOC HEALTH Inc is a consultant and received stockholder shares. 22) UnitedHealth Group Inc is a consultant and received stockholder shares. 23) Veeva Systems Inc Class A is a consultant and received stockholder shares. 24) Vanguard Index Funds S&P 500 ETF USD is a consultant and received stockholder shares.
Matthew I. Goldblatt, MD, FACS - Faculty, for this educational event, has financial relationship(s) with: 1) WL Gore, Inc as a consultant, speaking, and researcher and received both honorarium and research funding. 2) Medtronic as a consultant, speaking, and researcher and received both honorarium and research funding. 3) Intuitive Surgical as a proctor and received an honorarium. 4) Corza Medical as a consultant and received and honorarium.
D. Ryan Hall, MD, FACS - Faculty for this educational event has as no relevant financial relationship(s) with ineligible companies to disclose
Matthew Harting, MD, FACS - Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
John A. Harvin, MD, FACS - Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
Daniel N. Holena, MD, FACS - Faculty for this educational event has as no relevant financial relationship(s) with ineligible companies to disclose
Alexandra Istl, MD, FACS - Faculty for this educational event has as no relevant financial relationship(s) with ineligible companies to disclose.
Christina Jacovides, MD - Faculty for this educational event has as no relevant financial relationship(s) with ineligible companies to disclose
Ryan Juza, MD - Faculty for this educational event has as no relevant financial relationship(s) with ineligible companies to disclose
Kyle J. Kalkwarf, MD, FACS - Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
Andrew Kastenmeier, MD, FACS - Faculty, for this educational event, has financial relationship(s) with: Gore as an educator and received an honorarium.
David H. Kim, MD, FACS - Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
Tammy Kindel, MD, FACS - Faculty for this educational event has as no relevant financial relationship(s) with ineligible companies to disclose
Jordan Kirsch, DO - Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
Kimberly Kopecky, MD, MSCI - Faculty for this educational event has as no relevant financial relationship(s) with ineligible companies to disclose.
Anai Kothari, MD, FACS - Faculty, for this educational event, has financial relationship(s) with: Triomics, Inc as a PI and received a research grant.
Lindsay Kranker, MD - Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
Kelly J. Lafaro, MD, FACS - Faculty for this educational event has as no relevant financial relationship(s) with ineligible companies to disclose.
Sean Langenfeld, MD - Faculty for this educational event has as no relevant financial relationship(s) with ineligible companies to disclose
Meghan R. Lewis, MD, FACS - Faculty for this educational event has as no relevant financial relationship(s) with ineligible companies to disclose
Paul L. Linsky, MD, FACS - Faculty for this educational event has as no relevant financial relationship(s) with ineligible companies to disclose.
Kirk Ludwig, MD, FACS - Faculty for this educational event has as no relevant financial relationship(s) with ineligible companies to disclose.
Kristin M. Lupinacci, DO, FACS - Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
Allison N. Martin, MD - Faculty for this educational event has as no relevant financial relationship(s) with ineligible companies to disclose.
David E. Meyer, MD, FACS - Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
Laura J. Moore, MD, FACS - Faculty for this educational event, has financial relationship(s) with: 1) Frontline Medical Technologies as a Chair for the Clinical Adv. Board and received stock. 2) Decisio Health Inc is a Clinical Co-founder and received stock.
Rachel S. Morris, MD, FACS - Faculty, for this educational event, has financial relationship(s) with: 1) Advanced Trauma Analytics as CEO.
Eric M. Pauli, MD, FACS - Faculty, for this educational event, has financial relationship(s) with: 1) Becton-Dickinson as a speaker/teacher and received honrarium. 2) Medtronic as a speaker/teacher and received honrarium. 3) Boston Scientific as a consultant and received honorarium. 4) Actuated Medical as a consultant and received honorarium. 5) Cook Biotech as a consultant and received honorarium. 6) Neptune Medical as a consultant and received honorarium. 7) Surgimatix as a consultant and received honorarium. 8) Noah Medical as a consultant and received honorarium. 9) Allergan as a consultant and received honorarium. 10) Intuitive Surgical as a consultant and received honorarium. 11) ERBE as a consultant and received honorarium. 12) Integra as a consultant and received honorarium. 13) Steris as a consultant and received honorarium. 14) Mesh Suture Inc as a consultant and received honorarium. 15) UpToDate (Wolters Kluwer) as an editor and received royalties. 16) Springer as an editor and received royalties
Tamara E. Saunders, MD, FACS - Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
Michelle Shen, MD, FACS - Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
Carmen C. Solorzano, MD, FACS - Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
Melissa Stewart, MD, FACS - Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
Jonah Stulberg, MD, FACS - Faculty, for this educational event, has financial relationship(s) with: 1) Intuitive Surgical as a speaker and received consulting fees.
Ezra N. Teitelbaum, MD, FACS - Faculty, for this educational event, has financial relationship(s) with: Boston Scientific as a speaker and received consulting fees.
Rhea Udyavar, MD - Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
Dia Waguespack, MD - Faculty, for this educational event, has financial relationship(s) with: 1) Amgen as a speaker and received consulting fees. 2) Davita as a consultant and received stock.
Shihuan K. Wang, MD, RPVI - Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
Catherine M. Wittgen, MD, FACS - Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose
Continuing Medical Education Credit Information
Accreditation
The American College of Surgeons is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credits™
The American College of Surgeons designates this enduring activity for a maximum of 37.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Of the AMA PRA Category 1 Credits™ listed above, a maximum of 37.50 credits meet the requirements for Self-Assessment.
CME Credit Claiming Information
Please complete the overall course evaluation to claim a CME Certificate or a Certificate of Completion. The course evaluation will appear once you take and complete this course. The following requirements need to be completed:
- Complete the pre/posttest
- Review all course materials (videos and PDFs)
- Course evaluation
This course is available for claiming partial credit for AMA PRA Category 1 Credits™.
Participants may only claim a maximum of 37.50 AMA PRA Category 1 Credits™.
To receive Self-Assessment Credit for this course, participants must complete the posttest with a passing score of at least 75%. Learners that do not achieve a 75% or greater on their first try are able to retake the posttest, until a passing score is obtained.
Specialty Board Recognition
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program.
Available Credit
- 37.50 AMA PRA Category 1 Credit™
- 37.50 Certificate of Completion
- 37.50 Self Assessment Credit
Course Enrollment
You will be asked to enroll for the course and provide information to complete the process. Once you have completed the enrollment process, an email will be sent to you with the confirmation and course login information.
Course Fee
$975 for ACS members
$1365 for Non-members
Course cancelation and refund requests submitted after purchase will be evaluated on a case-by-case basis. Factors affecting the decision include whether the learner has accessed any course content.
To request a cancellation, please email registration@facs.org.
To Start Course
Once you have completed the enrollment process, you will see the "Take Course" button above, click on the button to start/access the educational activity.